期刊文献+

茶树菇Agrocybe aegerita新泛素偶联酶蛋白表达及抗肿瘤活性研究 被引量:2

Expression and Antitumor Activity of a Novel Ubiquitin Conjugating Enzyme from the Medicinal Fungus Agrocybe aegerita
原文传递
导出
摘要 大型真菌茶树菇活性蛋白组分Yt在动物模型中被发现具有抗肿瘤及免疫调节活性。为研究其蛋白组分,构建新鲜蘑菇子实体c DNA文库,对c DNA序列进行测序筛选,获得新型真菌泛素偶联酶(Ub-conjugating enzyme,UBC)的c DNA序列(Gen Bank登录代码:JQ362395),分析其含有UBC家族的保守残基。使用原核表达p ET系统表达和纯化重组UBC蛋白,得率是10 mg/L大肠杆菌培养液。在细胞培养中加入重组UBC蛋白将显著改变细胞形态,通过流式细胞仪发现UBC(1.8、3.6、7.2μM)均能诱导He La细胞凋亡,AnnexinⅤ+/PI-百分比由对照组的1.4%上调至10.7%、15.8%和20.3%,呈浓度依赖性。本文是首次报道真菌UBC具有抗肿瘤活性。该结果暗示,真菌泛素系统成员可能通过改变细胞基本生理功能,成为潜在的候选药物,值得探讨。 The active protein component Yt from macrofungi Agrocybe aegerita has been found to have antitumor and immune regulation activity. For the investigation of the proteins, a cDNA library of the Agrocybe aegerita fruiting body was constructed and screened. The cDNA of a novel fungal Ub-conjugating enzyme (UBC) was identified (Genbank accession code: JQ362395), and sequence analysis revealed that it contained the conserved residues and belonged to the UBC family. Recombinant UBC was expressed using the pET system and purified, and obtained 10 mg from 1 L E coli. culture media. Exogenously applied UBC (1.8, 3.6 and 7.2 μM) in cell cultures altered HeLa cell morphology and induced cell apoptosis determined by flow cytometry, and the percentage of AnnexinV+/PI- cells was increased from 1.4% in control to 10.7%, 15.8% and 20.3%, which was concentration dependent. This is the first report on the effects of a fungal UBC on cancer cells, which suggests that the members of the fungal ubiquitin system might alter fundamental cellular processes and require further investigation. © 2015, South China University of Technology. All right reserved.
出处 《现代食品科技》 EI CAS 北大核心 2015年第12期1-5,共5页 Modern Food Science and Technology
基金 国家自然科学基金(81102850) 广东省卫生厅基金(A2011434) 广东省教育厅育苗工程(LYM11070) 东莞市科技局项目(2011108102049) 湛江市科技攻关项目(2011C3109015)
关键词 大型真菌 凋亡活性 真菌泛素偶联酶 Cell culture Cell death Cytology Enzymes Fungi
  • 相关文献

参考文献15

  • 1Ben-Zion Zaidman,Majed Yassin,Jamal Mahajna,Solomon P. Wasser.??Medicinal mushroom modulators of molecular targets as cancer therapeutics(J)Applied Microbiology and Biotechnology . 2005 (4)
  • 2Elizabeth A Whitcomb,Allen Taylor.Ubiquitin control of S phase: a new role for the ubiquitin conjugating enzyme, UbcH7. Cell Division . 2009
  • 3Sarah E. Soss,Yuanyuan Yue,Sirano Dhe-Paganon,Walter J. Chaz.E2 Conjugating Enzyme Selectivity and Requirements for Function of the E3 Ubiquitin Ligase CHIP. Journal of Biological Chemistry . 2011
  • 4A. Maxwell Burroughs,Marcie Jaffee,Lakshminarayan M. Iyer,L. Aravind.??Anatomy of the E2 ligase fold: Implications for enzymology and evolution of ubiquitin/Ub-like protein conjugation(J)Journal of Structural Biology . 2007 (2)
  • 5Chenguang ZHAO,Hui SUN,Xin TONG,et al.An antitumour lectin from the edible mushroom Agrocybe aegerita. Biochemical Journal . 2003
  • 6梁一,郭莲仙,孙慧.茶树菇活性蛋白组分的体内抗肿瘤活性研究[J].现代食品科技,2014,30(7):1-5. 被引量:10
  • 7Riederer BM,Leuba G,Vernay A,et al.The role ofthe ubiquitin proteasome system in Alzheimer’’s disease. Experimental Biology and Medicine . 2011
  • 8Bedford Lynn,Lowe James,Dick Lawrence R,Mayer R John,Brownell James E.Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nature reviews. Drug discovery . 2010
  • 9BORCHERS A T,KEEN C L,GERSHWIN M E.Mushrooms,Tumors,and Immunity:An Update. Exp Biol Med(May-wood) . 2004
  • 10James J. Driscoll,Alex Minter,Daniel A. Driscoll,Jason K. Burris.??The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies(J)Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents) . 2011 (2)

二级参考文献15

  • 1卞冬萍,杨振泉,方维明.灰树花胞外多糖特性研究进展[J].现代食品科技,2006,22(3):247-250. 被引量:4
  • 2BORCHERS Andrea T, KEEN Carl L, GERSHWIN M Eric. Mushrooms, tumors, and immunity: an update [J]. Experimental Biology and Medicine (Maywood), 2004, 229(5): 393-406.
  • 3ZAIDMAN Ben-Zion, YASSIN Majed, MAHAJNA Jamal, et al. Medicinal mushroom modulators of molecular targets as cancer therapeutics [J]. Applied Microbiology and Biotechnology, 2005, 67(4): 453-468.
  • 4LIANG Yi, CHEN Yijie, LIU Honghong, et al. The tumor rejection effect of protein components from medicinal fungus [J]. Biomedicine & Preventive Nutrition, 2011,1 (4): 245-254.
  • 5Liang Yi, CHEN -ijie, SUN Hui. Antiturnor activity of protein component fraction and small molecule component fraction from agrocybe aegerita through enhancement of different cytokine production [J]. Journal of Medicinal Food, 2014, DOI 10.1089/jmf.2013.2846.
  • 6ASSELIN Barbara L. The three asparaginases, comparative pharmacology and optimal use in childhood leukemia [J]. Advances in Experimental Medicine and Biology, 1999, 457: 621-629.
  • 7DRUCKER Daniel J, BUSE John B, TAYLOR Kristin, et al.Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study [J]. Lancet, 2008, 372(9645): 1240-1250.
  • 8LI Jin-hua, KING Ada V, STICKEL Sara L, et al. Whole tumor cell vaccine with irradiated s180 cells as adjuvant [J]. Vaccine, 2009, 27(4): 558-564.
  • 9MORTON Donald L, EILBER Friedman R, MALMGREN Richard A, et al. Immunological factors which influence response to immunotherapy in malignant melanoma [J]. Surgery, 1970, 68(1): 158-163.
  • 10CHEN Shi-an, TSAI Ming-huan, WU Fu-tien, et al. Induction of antitumor immunity with combination of her2/neu dna vaccine and interleukin 2 gene-modified tumor vaccine [J]. Clinical Cancer Research, 2000, 6(11): 4381-4388.

共引文献10

同被引文献80

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部